Skip to content

Assessing Choice in the Employer Setting (ACES) Study

Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00808808
Acronym
MA181
Enrollment
4411
Registered
2008-12-16
Start date
2008-09-30
Completion date
2008-12-31
Last updated
2013-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

FluMist, TIV, vaccination rates

Brief summary

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

Detailed description

The primary objective is to determine, among adults in the 18-49 year old population and in the total population, the effects of offering a choice of FluMist or TIV with and without enhanced advertisement/added incentive on the overall influenza vaccination rates in the employer setting when compared to a control group.

Interventions

BIOLOGICALChoice of TIV or FluMist with baseline advertisement

An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist

OTHERChoice of TIV or FluMist with enhanced advertisement and incentives

An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination

BIOLOGICALControl - Usual care offering TIV only with baseline advertisement

A control arm of usual care offering TIV with baseline advertisement

Sponsors

Passport Health
CollaboratorINDUSTRY
University of Pittsburgh
CollaboratorOTHER
MedImmune LLC
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for employer sites: * Located in the United States * Has not previously offered FluMist in an employee vaccination program in the past or FluMist represented less than 5% of all vaccine received at past programs * Data are available that will allow for a reliable estimate of the employee (total and 18-49 year old populations) vaccination rate for the 2007-2008 influenza season

Design outcomes

Primary

MeasureTime frame
Overall Vaccination Rate, All Ages30Sep2008 through 23Dec2008
Overall Vaccination Rate, Employees 18 to 49 Years of Age30Sep2008 through 23Dec2008

Secondary

MeasureTime frameDescription
Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season30Sep2008 through 23Dec2008
Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Race30Sep2008 through 23Dec2008Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as white
Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population2007-2008 season through 2008-2009 seasonRate difference by arm from baseline to intervention season
Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Gender30Sep2008 through 23Dec2008Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as male.
Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Education30Sep2008 through 23Dec2008Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as college graduates.
Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age2007-2008 season through 2008-2009 seasonRate difference by arm from baseline to intervention season

Countries

United States

Participant flow

Recruitment details

Potential employers estimated to have at least 60 employees were contacted to determine their interest in participating in the study and were offered an influenza vaccine clinic on site at no cost. A screening questionnaire to determine eligibility was completed. Sites were excluded according to the study inclusion and exclusion criteria.

Participants by arm

ArmCount
Arm A (Control)
A control arm of usual care offering TIV with baseline advertisement
1,392
Arm B (Choice)
An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist
1,489
Arm C (Choice Plus)
An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination
2,132
Total5,013

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyEmployee was not vaccinated.2,6862,2682,255
Overall StudyVaccinated; survey not completed131169302

Baseline characteristics

CharacteristicArm A (Control)Arm B (Choice)Arm C (Choice Plus)Total
Age, Customized
18 to 49 years
983 participants988 participants1398 participants3369 participants
Age, Customized
≥ 50 years
409 participants501 participants734 participants1644 participants
Sex/Gender, Customized
Female
644 participants675 participants1324 participants2643 participants
Sex/Gender, Customized
Male
748 participants814 participants808 participants2370 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Overall Vaccination Rate, All Ages

Time frame: 30Sep2008 through 23Dec2008

Population: All employees at participating sites, including those who were vaccinated and those who were not

ArmMeasureValue (NUMBER)
Arm A (Control)Overall Vaccination Rate, All Ages41.6 Percentage of participants
Arm B (Choice)Overall Vaccination Rate, All Ages45.1 Percentage of participants
Arm C (Choice Plus)Overall Vaccination Rate, All Ages51.0 Percentage of participants
Primary

Overall Vaccination Rate, Employees 18 to 49 Years of Age

Time frame: 30Sep2008 through 23Dec2008

Population: All vaccinated employees at participating sites, including those who completed surveys and those who did not

ArmMeasureValue (NUMBER)
Arm A (Control)Overall Vaccination Rate, Employees 18 to 49 Years of Age38.5 Percentage of participants
Arm B (Choice)Overall Vaccination Rate, Employees 18 to 49 Years of Age40.9 Percentage of participants
Arm C (Choice Plus)Overall Vaccination Rate, Employees 18 to 49 Years of Age46.1 Percentage of participants
Secondary

Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age

Rate difference by arm from baseline to intervention season

Time frame: 2007-2008 season through 2008-2009 season

Population: All vaccinated employees 18-49 years of age at participating sites, including those who completed surveys and those who did not

ArmMeasureValue (NUMBER)
Arm A (Control)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age3.7 percentage points
Arm B (Choice)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age2.4 percentage points
Arm C (Choice Plus)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age9.7 percentage points
Secondary

Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population

Rate difference by arm from baseline to intervention season

Time frame: 2007-2008 season through 2008-2009 season

Population: All vaccinated employees at participating sites, including those who completed surveys and those who did not

ArmMeasureValue (NUMBER)
Arm A (Control)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population4.7 percentage points
Arm B (Choice)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population4.8 percentage points
Arm C (Choice Plus)Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population12.7 percentage points
Secondary

Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Education

Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as college graduates.

Time frame: 30Sep2008 through 23Dec2008

Population: All participants who completed surveys and were eligible to receive FluMist

ArmMeasureValue (NUMBER)
Arm A (Control)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Education73.4 percent
Arm B (Choice)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Education52.8 percent
Secondary

Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Gender

Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as male.

Time frame: 30Sep2008 through 23Dec2008

Population: All participants who completed surveys and were eligible to receive FluMist

ArmMeasureValue (NUMBER)
Arm A (Control)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Gender49.9 percent
Arm B (Choice)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Gender49.7 percent
Secondary

Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Race

Percent of participants 18-49 years of age who chose FluMist vs TIV for influenza vaccination and who self-identified as white

Time frame: 30Sep2008 through 23Dec2008

Population: All participants who completed surveys and were eligible to receive FluMist

ArmMeasureValue (NUMBER)
Arm A (Control)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Race67.8 percent
Arm B (Choice)Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Race71.8 percent
Secondary

Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season

Time frame: 30Sep2008 through 23Dec2008

Population: All vaccinated employees 18-49 years of age at participating sites, including those who completed surveys and those who did not

ArmMeasureValue (NUMBER)
Arm A (Control)Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season0.8 percent
Arm B (Choice)Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season19.1 percent
Arm C (Choice Plus)Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season26.8 percent

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026